Letters QRISK validation and evaluation

QRISK may be less useful

BMJ 2009; 339 doi: http://dx.doi.org/10.1136/bmj.b3485 (Published 01 September 2009) Cite this as: BMJ 2009;339:b3485
  1. Su May Liew, research student1,
  2. Paul Glasziou, professor1
  1. 1Centre for Evidence-Based Medicine, Department of Primary Health Care, University of Oxford OX3 7LF
  1. su.liew{at}dphpc.ox.ac.uk

    Collins and Altman inappropriately criticise the National Institute for Health and Clinical Excellence (NICE) for not choosing QRISK to predict cardiovascular risk.1 In doing so, they do not distinguish between assessing individual cardiovascular risk (as used by clinicians) and predicting risk of cardiovascular events in an actively managed population (as used in public health planning). As …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial